Predictors of Successful First-line Antimuscarinic Monotherapy in Men With Enlarged Prostate and Predominant Storage Symptoms

First-line antimuscarinic monotherapy is safe and effective within 12 weeks in selected patients with benign prostatic hyperplasia (BPH) Higher baseline IPSS-S, higher baseline Qmax, and lower TPV were predictors of successful antimuscarinic monotherapy.